메뉴 건너뛰기




Volumn 53, Issue 11, 2012, Pages 2143-2150

Interim [18F]fluorodeoxyglucose positron emission tomography imaging in stage III non-bulky Hodgkin lymphoma: Would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?

Author keywords

interim PET CT; Lymphoma and Hodgkin disease; therapy response

Indexed keywords

DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; GEMCITABINE; VINBLASTINE;

EID: 84867186026     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.676173     Document Type: Article
Times cited : (48)

References (41)
  • 1
    • 0022600848 scopus 로고
    • Chemotherapy for diffuse large-cell lymphoma - Rapidly responding patients have more durable remissions
    • Armitage JO, Weisenburger DD, Hutchins M, et al. Chemotherapy for diffuse large-cell lymphoma-rapidly responding patients have more durable remissions. J Clin Oncol 1986;4:160-164. (Pubitemid 16161030)
    • (1986) Journal of Clinical Oncology , vol.4 , Issue.2 , pp. 160-164
    • Armitage, J.O.1    Weisenburger, D.D.2    Hutchins, M.3
  • 2
    • 0028297107 scopus 로고
    • Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: A literature review
    • Haw R, Sawka CA, Franssen E, et al. Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: a literature review. J Clin Oncol 1994;12:1074-1084. (Pubitemid 24145339)
    • (1994) Journal of Clinical Oncology , vol.12 , Issue.5 , pp. 1074-1084
    • Haq, R.1    Sawka, C.A.2    Franssen, E.3    Berinstein, N.L.4
  • 4
    • 0023898728 scopus 로고
    • The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease
    • Radford JA, Cowan RA, Flanagan M, et al. The signif cance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol 1988;6:940-946.
    • (1988) J Clin Oncol , vol.6 , pp. 940-946
    • Radford, J.A.1    Cowan, R.A.2    Flanagan, M.3
  • 6
    • 25444437438 scopus 로고    scopus 로고
    • Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma
    • DOI 10.1093/annonc/mdi200
    • Hutchings M, Mikhaeel NG, Fields PA, et al. Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma. Ann Oncol 2005;16:1160-1168. (Pubitemid 41418320)
    • (2005) Annals of Oncology , vol.16 , Issue.7 , pp. 1160-1168
    • Hutchings, M.1    Mikhaeel, N.G.2    Fields, P.A.3    Nunan, T.4    Timothy, A.R.5
  • 8
    • 33645998113 scopus 로고    scopus 로고
    • The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease
    • Gallamini A, Rigacci L, Merli F, et al. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. Haematologica 2006;91:475-481.
    • (2006) Haematologica , vol.91 , pp. 475-481
    • Gallamini, A.1    Rigacci, L.2    Merli, F.3
  • 12
    • 64649093421 scopus 로고    scopus 로고
    • Fluorine-18-f uorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: A systematic review
    • Terasawa T, Lau J, Bardet S, et al. Fluorine-18-f uorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review. J Clin Oncol 2009;27:1906-1914.
    • (2009) J Clin Oncol , vol.27 , pp. 1906-1914
    • Terasawa, T.1    Lau, J.2    Bardet, S.3
  • 14
    • 70349753332 scopus 로고    scopus 로고
    • Report on the first international workshop on interim-pet scan in lymphoma
    • Meignan M, Gallamini A, Haioun C. Report on the First International Workshop on Interim-PET Scan in Lymphoma. Leuk Lymphoma 2009;50:1257-1260.
    • (2009) Leuk Lymphoma , vol.50 , pp. 1257-1260
    • Meignan, M.1    Gallamini, A.2    Haioun, C.3
  • 15
    • 79952114063 scopus 로고    scopus 로고
    • Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma
    • Barrington SF, Qian W, Somer E, et al. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 2010;37:1824-1833.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , pp. 1824-1833
    • Barrington, S.F.1    Qian, W.2    Somer, E.3
  • 16
    • 79956356218 scopus 로고    scopus 로고
    • Doxorubicin vinblastine gemcitabine (CALGB 50203) for stage I/II non-bulky Hodgkin lymphoma: Pretreatment prognostic factors and interim PET
    • Straus DJ, Johnson JL, Lacasce AS, et al. Doxorubicin, vinblastine, gemcitabine (CALGB 50203) for stage I/II non-bulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET. Blood 2011;117:5314-5320.
    • (2011) Blood , vol.117 , pp. 5314-5320
    • Straus, D.J.1    Johnson, J.L.2    Lacasce, A.S.3
  • 17
    • 0042449063 scopus 로고    scopus 로고
    • Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group
    • Cheson BD, Horning SJ, Coifier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17:1244.
    • (1999) J Clin Oncol , vol.17 , pp. 1244
    • Cheson, B.D.1    Horning, S.J.2    Coifer, B.3
  • 19
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan DL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, D.L.1    Meier, P.2
  • 20
    • 0000957062 scopus 로고
    • Asymptotically ef cient rank invariant test procedures
    • Peto R, Peto J. Asymptotically ef cient rank invariant test procedures. J R Stat Soc A 1972;135:185-207.
    • (1972) J R Stat Soc A , vol.135 , pp. 185-207
    • Peto, R.1    Peto, J.2
  • 21
    • 0000596361 scopus 로고
    • Note on the sampling error of the dif erence between correlated proportions or percentages
    • McNemar Q. Note on the sampling error of the dif erence between correlated proportions or percentages. Psychometrika 1947;12:153-157.
    • (1947) Psychometrika , vol.12 , pp. 153-157
    • McNemar, Q.1
  • 22
    • 79953297062 scopus 로고    scopus 로고
    • End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma
    • Barnes JA, Lacasce AS, Zukotynski K, et al. End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma. Ann Oncol 2011;22:910-915.
    • (2011) Ann Oncol , vol.22 , pp. 910-915
    • Barnes, J.A.1    Lacasce, A.S.2    Zukotynski, K.3
  • 23
    • 77951925455 scopus 로고    scopus 로고
    • Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy
    • Canellos GP, Abramson JS, Fisher DC, et al. Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy. J Clin Oncol 2010;28:1611-1615.
    • (2010) J Clin Oncol , vol.28 , pp. 1611-1615
    • Canellos, G.P.1    Abramson, J.S.2    Fisher, D.C.3
  • 24
    • 77957945999 scopus 로고    scopus 로고
    • Intensif ed chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: Final analysis of the German Hodgkin Study Group HD11 Trial
    • Eich HT, Diehl V, Gorgen H, et al. Intensif ed chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 Trial. J Clin Oncol 2010;28:4199-4206.
    • (2010) J Clin Oncol , vol.28 , pp. 4199-4206
    • Eich, H.T.1    Diehl, V.2    Gorgen, H.3
  • 25
    • 77956646155 scopus 로고    scopus 로고
    • Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma
    • Engert A, Plutschow A, Eich HT, et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med 2010;363:640-652.
    • (2010) N Engl J Med , vol.363 , pp. 640-652
    • Engert, A.1    Plutschow, A.2    Eich, H.T.3
  • 26
    • 84858785381 scopus 로고    scopus 로고
    • Early interim (18)F-FDG PET in Hodgkin's lymphoma: Evaluation on 304 patients
    • Zinzani PL, Rigacci L, Stefoni V, et al. Early interim (18)F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients. Eur J Nucl Med Mol Imaging 2012;39:4-12.
    • (2012) Eur J Nucl Med Mol Imaging , vol.39 , pp. 4-12
    • Zinzani, P.L.1    Rigacci, L.2    Stefoni, V.3
  • 27
    • 84879143104 scopus 로고    scopus 로고
    • First report on the H10 EORTC/GELA/IIL randomized intergroup trial on early FDG-PET scan guided treatment adaptation versus standard combined modality treatment in patients with supra-diaphragmatic stage I/II Hodgkin's lymphoma for the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
    • European Organisation for the Research and Treatment of Cancer (EORTC) Lymphoma Group and the Intergruppo Italiano Linfomi (IIL) Abstract 97
    • Marc APE, Reman O, Federico M, et al. First report on the H10 EORTC/GELA/IIL randomized intergroup trial on early FDG-PET scan guided treatment adaptation versus standard combined modality treatment in patients with supra-diaphragmatic stage I/II Hodgkin's lymphoma, for the Groupe d'Etude Des Lymphomes De l'Adulte (GELA), European Organisation for the Research and Treatment of Cancer (EORTC) Lymphoma Group and the Intergruppo Italiano Linfomi (IIL). Blood 2009;114(Suppl. 1): Abstract 97.
    • (2009) Blood , vol.114 , Issue.SUPPL. 1
    • Marc, A.P.E.1    Reman, O.2    Federico, M.3
  • 28
    • 84879169926 scopus 로고    scopus 로고
    • Early interim FDG-PET scan in localised Hodgkin lymphoma: Evaluation of practice in 5 French centers
    • Abstract 4935
    • Fitoussi O, Brice P, Hirt S, et al. Early interim FDG-PET scan in localised Hodgkin lymphoma: evaluation of practice in 5 French centers. Blood 2008;112(Suppl. 1): Abstract 4935.
    • (2008) Blood , vol.112 , Issue.SUPPL. 1
    • Fitoussi, O.1    Brice, P.2    Hirt, S.3
  • 29
    • 84879186685 scopus 로고    scopus 로고
    • Predictive role of early interim FDG-PET in Hodgkin lymphoma
    • Abstract 1659
    • Stefoni V, Broccoli A, Alinari L, et al. Predictive role of early interim FDG-PET in Hodgkin lymphoma. Blood 2009;114(Suppl. 1): Abstract 1659.
    • (2009) Blood , vol.114 , Issue.SUPPL. 1
    • Stefoni, V.1    Broccoli, A.2    Alinari, L.3
  • 30
    • 68749112687 scopus 로고    scopus 로고
    • Results of the 2nd planned interim analysis of the RAPID Trial (involved field radiotherapy versus no further treatment) in patients with clinical stages 1A and 2A Hodgkin lymphoma and negative FDG-PET scan after 3 cycles ABVD
    • Abstract 369
    • Radford J, O'Doherty M, Barrington S, et al. Results of the 2nd planned interim analysis of the RAPID Trial (involved field radiotherapy versus no further treatment) in patients with clinical stages 1A and 2A Hodgkin lymphoma and negative FDG-PET scan after 3 cycles ABVD. Blood 2008;112(Suppl. 1): Abstract 369.
    • (2008) Blood , vol.112 , Issue.SUPPL. 1
    • Radford, J.1    O'Doherty, M.2    Barrington, S.3
  • 31
    • 9444292843 scopus 로고    scopus 로고
    • Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease
    • DOI 10.1182/blood-2004-04-1311
    • Straus DJ, Portlock CS, Qin J, et al. Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease. Blood 2004;104:3483-3489. (Pubitemid 39564416)
    • (2004) Blood , vol.104 , Issue.12 , pp. 3483-3489
    • Straus, D.J.1    Portlock, C.S.2    Qin, J.3    Myers, J.4    Zelenetz, A.D.5    Moskowitz, C.6    Noy, A.7    Goy, A.8    Yahalom, J.9
  • 33
    • 79952232711 scopus 로고    scopus 로고
    • Interim FDG-PET scan in Hodgkin's lymphoma: Hopes and caveats
    • Andre M, Vander Borght T, Bosly A. Interim FDG-PET scan in Hodgkin's lymphoma: hopes and caveats. Adv Hematol 2011;2011:430679.
    • (2011) Adv Hematol , vol.2011 , pp. 430679
    • Andre, M.1    Vander Borght, T.2    Bosly, A.3
  • 34
    • 66149154689 scopus 로고    scopus 로고
    • PET/CT for therapy response assessment in lymphoma
    • Hutchings M, Barrington SF. PET/CT for therapy response assessment in lymphoma. J Nucl Med 2009;50:21S-30S.
    • (2009) J Nucl Med , vol.50
    • Hutchings, M.1    Barrington, S.F.2
  • 35
    • 71049116335 scopus 로고    scopus 로고
    • Prognostic signif cance of mid-and post-ABVD PET imaging in Hodgkin's lymphoma: The importance of involved-field radiotherapy
    • Sher DJ, Mauch PM, Van Den Abbeele A, et al. Prognostic signif cance of mid-and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy. Ann Oncol 2009;20:1848-1853.
    • (2009) Ann Oncol , vol.20 , pp. 1848-1853
    • Sher, D.J.1    Mauch, P.M.2    Van Den Abbeele, A.3
  • 37
    • 77949345555 scopus 로고    scopus 로고
    • Tumor-associated macrophages and survival in classic Hodgkin's lymphoma
    • Steidl C, Lee T, Shah SP, et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010;362:875-885.
    • (2010) N Engl J Med , vol.362 , pp. 875-885
    • Steidl, C.1    Lee, T.2    Shah, S.P.3
  • 38
    • 79958067512 scopus 로고    scopus 로고
    • Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: Comparison of International Harmonization Project (IHP), Gallamini and London criteria
    • Le Roux PY, Gastinne T, Le Gouill S, et al. Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria. Eur J Nucl Med Mol Imaging 2011;38:1064-1071.
    • (2011) Eur J Nucl Med Mol Imaging , vol.38 , pp. 1064-1071
    • Le Roux, P.Y.1    Gastinne, T.2    Le Gouill, S.3
  • 39
    • 0024214663 scopus 로고
    • A Gompertzian model of human breast cancer growth
    • Norton L. A Gompertzian model of human breast cancer growth. Cancer Res 1988;48:7067-7071. (Pubitemid 19013983)
    • (1988) Cancer Research , vol.48 , Issue.24 , pp. 7067-7071
    • Norton, L.1
  • 40
    • 0022600727 scopus 로고
    • The Norton-Simon hypothesis revisited
    • Norton L, Simon R. The Norton-Simon hypothesis revisited. Cancer Treat Rep 1986; 70:163-169. (Pubitemid 16140378)
    • (1986) Cancer Treatment Reports , vol.70 , Issue.1 , pp. 163-169
    • Norton, L.1    Simon, R.2
  • 41
    • 0034660890 scopus 로고    scopus 로고
    • Fractals and cancer
    • Baish JW, Jain R. Fractals and cancer. Cancer Res 2000;60:3683-3688. (Pubitemid 32204551)
    • (2000) Cancer Research , vol.60 , Issue.14 , pp. 3683-3688
    • Baish, J.W.1    Jain, R.K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.